Dallas, Texas
United States
14
2026-03-26
2
2022-10-18
These are the the leading inventors for applications assigned to Lantern Pharma Inc.:
Lantern Pharma Inc. based in Dallas, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
TREATING CANCERS WITH COMBINATIONS OF ANTI-CD20 ANTIBODY AND ACYLFULVENES
#2 | 2026-01-08MACHINE LEARNING SYSTEM AND METHOD FOR PREDICTING BLOOD BRAIN BARRIER PERMEABILITY
#3 | 2026-01-08METHOD FOR TREATING RENAL CELL CARCINOMA OR CANCER
#4 | 2025-05-22METHOD FOR TREATING BREAST CANCERS AND PARP RESISTANT BREAST CANCERS
#5 | 2025-03-27TREATING CANCERS WITH COMBINATIONS OF ACYLFULVENES WITH IBRUTINIB AND/OR BORTEZOMIB
#6 | 2024-12-26COMPUTERIZED SYSTEMS AND METHODS FOR ENSEMBLE MODEL-BASED DRUG DISCOVERY
#7 | 2024-12-05Treating Cancers with Combinations of Spironolactone and Acylfulvenes
#8 | 2024-09-12TREATING CANCERS WITH COMBINATIONS OF PARP INHIBITOR AND ACYLFULVENES
#9 | 2024-09-12METHOD FOR TREATING CANCER WITH ACYLFULVENE AND RADIATION
#10 | 2024-03-14Method for Treating Blood Cancers
#11 | 2023-12-14ILLUDIN ANALOGS, USES THEREOF, AND METHODS FOR SYNTHESIZING THE SAME
#12 | 2023-07-06Increasing Cancer Patient Survival Time by Administration of Dithio-Containing Compounds
#13 | 2018-12-27 ✅ Patent 11,471,431 granted on 2022-10-18Increasing cancer patient survival time by administration of dithio-containing compounds
#14 | 2016-10-06 ✅ Patent 11,471,431 granted on 2022-10-18Increasing cancer patient survival time by administration of dithio-containing compounds
Also check out Lantern Pharma Inc.'s (Dallas, United States) applicant profile with 15 patent applications submitted.
339022 ⎘